These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 35782

  • 1. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
    Herman ZS, Słomińska-Zurek J, Kryk A, Kmieciak-Kołada K.
    Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
    [Abstract] [Full Text] [Related]

  • 2. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
    Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1979; 31(5):473-80. PubMed ID: 575732
    [Abstract] [Full Text] [Related]

  • 3. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D, Fidecka S, Langwiński R.
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [Abstract] [Full Text] [Related]

  • 4. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D, Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ, Bapat TR, Chandorkar AG.
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [Abstract] [Full Text] [Related]

  • 7. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I, Petöcz L, Fekete MI, Bükkfálvi B, Görgenyi F, Arató M.
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [Abstract] [Full Text] [Related]

  • 8. The effect of lesions of raphe nuclei on the cataleptic action of neuroleptics.
    Przewłocka B, Kukułka L, Tatarczyńska E.
    Pol J Pharmacol Pharm; 1977; 29(6):581-9. PubMed ID: 23522
    [Abstract] [Full Text] [Related]

  • 9. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG, Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Balsara JJ.
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [Abstract] [Full Text] [Related]

  • 10. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV, Gaonkar RK, Jadhav SA, Thorat VM, Jadhav JH, Balsara JJ.
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [Abstract] [Full Text] [Related]

  • 11. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK, Jaskiw GE, Braun AR, Weinberger DR.
    Biol Psychiatry; 1995 Aug 15; 38(4):255-62. PubMed ID: 8547448
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain.
    Poddubiuk ZM, Kleinrok Z.
    Psychopharmacology (Berl); 1976 Oct 20; 50(1):95-102. PubMed ID: 138146
    [Abstract] [Full Text] [Related]

  • 13. [Effect of neuroleptics on foot-pedal self stimulation from the ventral tegmentum mesencephali in rats and its correlation with cataleptogenic action].
    Talalaenko AN, Boreĭsha IK, Zin'kovskaia LIa.
    Farmakol Toksikol; 1982 Oct 20; 45(2):19-22. PubMed ID: 6122595
    [Abstract] [Full Text] [Related]

  • 14. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G.
    Acta Pol Pharm; 2000 Oct 20; 57(3):233-7. PubMed ID: 11143713
    [Abstract] [Full Text] [Related]

  • 15. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D, Markovska V.
    Acta Physiol Pharmacol Bulg; 1988 Oct 20; 14(2):56-62. PubMed ID: 2851915
    [Abstract] [Full Text] [Related]

  • 16. [The role of the genotype in the cataleptogenic effect of neuroleptics].
    Skrinskaia IuA, Nikulina EM, Popova NK.
    Eksp Klin Farmakol; 1992 Oct 20; 55(6):7-9. PubMed ID: 1363957
    [Abstract] [Full Text] [Related]

  • 17. [Lithium modifications of the cataleptogenic properties of various neuroleptic drugs in the rat].
    Dessaigne S, Scotto AM, Guigues M.
    C R Seances Soc Biol Fil; 1978 Oct 20; 172(6):1173-80. PubMed ID: 40676
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
    Usuda S, Sano K, Maeno H.
    Arch Int Pharmacodyn Ther; 1979 Sep 20; 241(1):68-78. PubMed ID: 43118
    [Abstract] [Full Text] [Related]

  • 19. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B, Holmes SW, Kelly ME, Naylor RJ.
    Br J Pharmacol; 1985 Aug 20; 85(4):943-9. PubMed ID: 3862460
    [Abstract] [Full Text] [Related]

  • 20. Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.
    McMillen BA, German DC, Sanghere MK, Warnack W, Shore PA.
    J Pharmacol Exp Ther; 1980 Oct 20; 215(1):150-5. PubMed ID: 6109013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.